PJ-008200 Measurements on healthy subjects to design a nociception index
Not Applicable
Completed
- Registration Number
- NL-OMON28208
- Lead Sponsor
- Philips
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
een gezonde man of vrouw bent tussen de 18 en 65 jaar
Exclusion Criteria
|
1) Zwangerschap (zwangerschapstest vóór startprotocol, indien vrouwelijk, met uitzondering van postmenstruele |
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint of the study is the correlation between the presence of nociception and measures of nociception (features derived from ECG, ABP, PPG (pulsations in finger), GSR (sweatproduction on hand) EEG and facial recordings)</p><br>
- Secondary Outcome Measures
Name Time Method <p>- the effect of remifentanil on the correlation between the index of nociception and the stimulus strenghts and related NRS scores - the performance of within Philips Research erlier developed vital sign based (i.e.HRV, BP) algorithms - the index of nociception with indices on the market such as ANI - the performance of the PainCheck facial expressions algorithm for pain detection</p><br>